Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surveillance for Second Breast Cancer With Abbreviated Breast MRI, Ultrasound, and Mammography in Women With BRCA Mutation Testing

NCT03475979 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03475979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03475979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surveillance for Second Breast Cancer With Abbreviated Breast MRI, Ultrasound, and Mammography in Women With BRCA Mutation Testing
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2018
Completion date
June 30, 2022
Enrollment
1,564 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, brca2 mutation, breast cancer, metachronous neoplasm, recurrent breast cancer